Nektar Therapeutics (NASDAQ:NKTR)

0.6037
Delayed Data
As of Jun 05
 -0.0093 / -1.50%
Today’s Change
0.58
Today|||52-Week Range
5.18
-73.29%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zalevsky Jonathan
Chief Research & Development Officer
Sale8/18/202273,716$4.65$342.8K-86.97%
Robin Howard W
President & Chief Executive Officer
Sale11/16/202238,014$3.57$135.7K-82.67%
Eastham Karin
Director
Sale9/13/202221,267$3.61$76.8K-82.82%
Robin Howard W
President & Chief Executive Officer
Sale8/16/202213,759$4.76$65.5K-86.97%
Robin Howard W
President & Chief Executive Officer
Sale2/16/202319,635$3.00$58.9K-79.53%
Zalevsky Jonathan
Chief Research & Development Officer
Sale8/16/202210,560$4.76$50.3K-86.97%
Zalevsky Jonathan
Chief Research & Development Officer
Sale11/16/202213,460$3.57$48.1K-82.67%
Thomsen Jillian B
Chief Financial Officer
Sale11/16/202211,095$3.57$39.6K-82.67%
Zalevsky Jonathan
Chief Research & Development Officer
Sale2/16/202310,484$3.00$31.5K-79.53%
Wilson Mark A /nextkar/
Chief Legal Officer
Sale11/16/20228,690$3.57$31.0K-82.67%
Page of 4